Compound 299
Identifiers
- Canonical SMILES:
CC(C)C[C@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12
- IUPAC name:
1-[4-benzoyl-3-(2-methylpropyl)piperazin-1-yl]-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione
- InChi:
InChI=1S/C25H26FN3O3/c1-16(2)13-18-15-28(11-12-29(18)24(31)17-7-4-3-5-8-17)25(32)23(30)19-14-27-21-10-6-9-20(26)22(19)21/h3-10,14,16,18,27H,11-13,15H2,1-2H3/t18-/m0/s1
- InChiKey:
WSCMWUHPGDJGCX-SFHVURJKSA-N
External links
168318246 |
24635022 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 6.52 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 435.20 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 3.97 | |||
TPSA | 73.48 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6928 | Talmapimod | DB05412 | |
0.6642 | LY-517717 | DB05713 | |
0.6488 | Indoramin | DB08950 | |
0.6216 | LTX-315 | DB12748 | |
0.6216 | Gramicidin D | DB00027 | |
0.6133 | TC-6987 | DB14854 | |
0.5987 | Omiganan | DB06610 | |
0.5933 | Macimorelin | DB13074 | |
0.5849 | BQ-123 | DB12054 | |
0.5809 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.5806 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | DB04724 | |
0.5776 | Murepavadin | DB14777 | |
0.5769 | Ilomastat | DB02255 | |
0.5753 | Pruvanserin | DB13094 | |
0.5750 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID | DB08493 |